Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video chat lessons may help COPD patients catch Zzz's

NCT ID NCT07311499

Symptom relief Sponsor: Kumamoto University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether teaching COPD patients how to use their inhalers correctly, via video calls with a nurse, can improve their sleep quality. Researchers will compare sleep scores between those who get the education and those who don't. Sixty adults who already use inhaled medications will keep a diary of symptoms and rescue inhaler use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals aged 20 years or older at the time of consent. * Individuals who have been prescribed inhaled medications and have been using them continuously for more than one month. * Prior experience with inhalation instruction is not required. * Individuals who have not been hospitalized within one month prior to study participation due to exacerbation of COPD. * Individuals with obstructive sleep apnea syndrome (OSAS) who are receiving treatment with continuous positive airway pressure (CPAP) therapy are eligible, provided that the physician determines that symptoms are stable following CPAP initiation. * Participants must be able to operate devices such as Android, iPad, or computer. However, if a caregiver can operate the device, the participant's inability to do so is acceptable. * Participants must be in a stable condition as determined by a physician and have obtained permission to participate. Exclusion Criteria: * Suffering from other respiratory diseases such as asthma or interstitial pneumonia * Suffering from advanced cancer, including lung cancer * Restricted chest movement due to chest deformity or trauma * Suffering from diseases that cause respiratory distress, such as heart disease * Suffering from sleep-disordered breathing with a central AHI of more than 50% * Diagnosed with dementia or mental illness

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive lung disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive lung disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kumamoto University

    Kumamoto, Chuo-ku, 862-0976, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.